Menu
Your Cart

About Us

Apostle Inc is a biotechnology company in San Jose, CA, a provider of innovative technologies and services for public health and life sciences. 


Apostle aims to develop innovative technologies in the space of liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing circulating free DNA (cfDNA) as a biomarker. Apostle’s innovations include Apostle MiniMax, a new scalable and automatable method to efficiently capture cfDNA from a standard blood draw; Apostle MagTouch, a nucleic acids isolation automation system, and Apostle MiniEnrich, a high-resolution DNA size enrichment technology using a magnetic nano-platform.  Since 2020, the company has also responded to the global COVID-19 pandemic, and helped our community fight together with a high quality, low cost, fast, automated, Apostle COVID-19 Viral RNA Isolation System.


Up to date, the company's products have served over 20 million people by our clients, while we are striving every day in our work to improve and benefit public health and life sciences.

Accreditations

Team - Scientific Advisory Board

Team - Management

Apostle technologies have been cited or discussed in the following publications.

Track Record of Publications

Apostle Diagnostics

StartX Med

Location

Using Apostle MiniMax cfDNA Isolation Technology a recent clinical study in 2821 myeloid or lymphoid neoplasm patients shows that liquid biopsy using targeted NGS is reliable in detecting chromosomal structural abnomalities in myeloid neoplasms. The study supports the use of liquid biopsy for early diagnosis and monitoring of patients with myeloid neoplasms. Read article